NASDAQ · Medical - Instruments & Supplies

OSUR (OSUR) Stock

$4.05 +1.25% NASDAQ: OSUR Healthcare

Valuation

MetricValue
Price$4.05
Market Cap$278.84M
P/E Ratio-3.29
P/B Ratio0.62
P/S Ratio1.88
EPS (TTM)$-0.94
52-Week High$4.58
52-Week Low$2.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.23%
ROA-17.12%
ROCE-19.94%
Gross Margin-59.13%
Operating Margin-59.13%
Net Margin-66.42%
Debt/Equity0.13
Current Ratio6.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$234.0M$387.0M$405.0M$186.0M$115.0M
Operating Profit$-12.0M$-5.0M$54.0M$-21.0M$-68.0M
Net Profit$-23.0M$-17.0M$54.0M$-19.0M$-69.0M
EPS$-0.32$-0.25$0.72$-0.26$-0.94
Op Margin-5.0%-1.4%13.3%-11.1%-59.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$461.0M$444.0M$483.0M$480.0M$403.0M
Total Liabilities$80.0M$80.0M$52.0M$69.0M$62.0M
Cash$117.0M$84.0M$290.0M$268.0M$199.0M
Borrowings$12.0M$13.0M$14.0M$15.0M$13.0M

Latest News

OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing MT Newswires · Jun 11, 2026 OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections GlobeNewswire · Jun 11, 2026 Is Co-Diagnostics National Security’s Next Diagnostic Pick? MarketBeat · May 28, 2026 Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist Simply Wall St. · May 20, 2026 OraSure Technologies Independent Director Acquires 195% More Stock Simply Wall St. · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-47.0M$142.0M$27.0M$0
Investing Cash Flow$-54.0M$-43.0M$56.0M$-43.0M$0
Financing Cash Flow$-2.0M$-2.0M$-2.0M$-3.0M$0
Net Cash Flow$-44.0M$-33.0M$206.0M$-23.0M$0
Free Cash Flow$-83.0M$-111.0M$131.0M$24.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield0.00%
Quick Ratio5.78
Interest Coverage—
Return 1Y22.12%
Return 3Y-10.24%
Return 5Y-57.31%

Ownership

Insiders Held6.38%
Institutions Held89.12%
Institutions Float Held95.19%
Institutional HolderSharesReport Date
Blackrock Inc.6,516,2162026-03-31
Private Management Group, Inc.5,422,1292026-03-31
Neuberger Berman Group, LLC4,361,9012026-03-31
Altai Capital Management, L.p.3,613,8362026-03-31
Vanguard Capital Management LLC3,030,8882026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
NAUT $1.20 -27.71% -5.06 $152.49M 0.00%
NTHINeonc Technologies Holdings, Inc. $3.44 +0.29% -1.77 $89.21M 0.00%
NYXH $1.41 -2.76% -1.23 $55.85M 0.00%

About OSUR

OSUR is led by CEO Carrie Eglinton Manner, employs 501 people, headquartered in US, publicly traded since 1986.

OSUR stock trades at $4.05 with a market capitalization of $278.84M. The stock is valued at a price-to-earnings (P/E) ratio of -3.29, price-to-book of 0.62, price-to-sales of 1.88. Over the past 52 weeks the stock has ranged between $2.08 and $4.58, and currently trades 11.6% below its 52-week high.

On profitability, OSUR generates a return on equity (ROE) of -20.23%, return on capital employed of -19.94%, an operating margin of -59.13%, a net profit margin of -66.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides